TrialAlimentary pharmacology & therapeutics2017

Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype.

M M T J Broekman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.